Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer

Oncogene

Volumn 26, Issue 1, 2007, Pages 132-141

  Bacon, A L ^a   Fox, S ^a   Turley, H ^a   Harris, A L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

BNIP3; HIF; Histone deacetylation; Hypoxia; Silencing

Indexed keywords

HISTONE; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN BCL 2; PROTEIN BNIP3; TRICHOSTATIN A;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN CACO 2; CELL STRAIN HCT116; CELL STRAIN HT29; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DEACETYLATION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; STATISTICAL SIGNIFICANCE;

ACETYLATION; BASE SEQUENCE; BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL NEOPLASMS; DNA METHYLATION; GENE SILENCING; HISTONES; HUMANS; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

ADENOVIRIDAE;

EID: 33846094145     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209761     Document Type: Article

References (39)

1. Bacon AL, Harris AL. (2004). Ann Med 36: 530-539.
2. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K et al. (2002). Cancer Res 62: 2493-2497.
3. Bruick RK. (2000). Proc Natl Acad Sci USA 97: 9082-9087.
4. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. (1999). Trends Cell Biol 9: M57-M60.
5. Chen G, Ray R, Dubik D, Shi L, Cizeau J, Bleackley RC et al. (1997). J Exp Med 186: 1975-1983.
6. Elbashir SM, Harborth J, Weber K, Tuschl T. (2002). Methods 26: 199-213.
7. Erler JT, Cawthorne CJ, Williams KJ, Koritzinsky M, Wouters BG, Wilson C et al. (2004). Mol Cell Biol 24: 2875-2889.
8. Fearon ER, Vogelstein B. (1990). Cell 61: 759-767.
9. Fei P, Wang W, Kim SH, Wang S, Burns TF, Sax JK et al. (2004). Cancer Cell 6: 597-609.
10. Giatromanolaki A, Koukourakis MI, Sowter HM, Sivridis E, Gibson S, Gatter KC et al. (2004). Clin Cancer Res 10: 5566-5571.
11. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW et al. (1996). Nature 379: 88-91.
12. Harris AL. (2002). Nat Rev Cancer 2: 38-47.
13. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. (1996). Proc Natl Acad Sci USA 93: 9821-9826.
14. Hockel M, Schlenger K, Hockel S, Aral B, Schaffer U, Vaupel P. (1998). Int J Cancer 79: 365-369.
15. Hockel M, Vaupel P. (2001). J Natl Cancer Inst 93: 266-276.
16. Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH. (2004). J Exp Med 199: 113-124.
17. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW et al. (2001). Nat Med 7: 437-443.
18. Kinzler KW, Vogelstein B. (1996). Cell 87: 159-170.
19. Knowles HJ, Harris AL. (2001). Breast Cancer Res 3: 318-322.
20. Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K et al. (2003). Oncogene 22: 4734-4744.
21. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. (2002). Proc Natl Acad Sci USA 99: 12825-12830.
22. Lee MJ, Kim JY, Suk K, Park JH. (2004). Mol Cell Biol 24: 3918-3927.
23. Levine AJ. (1997). Cell 88: 323-331.
24. Magdinier F, Wolffe AP. (2001). Proc Natl Acad Sci USA 98: 4990-4995.
25. Murai M, Toyota M, Satoh A, Suzuki H, Akino K, Mita H et al. (2005a). Br J Cancer 92: 1165-1172.
26. Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, Akino K et al. (2005b). Clin Cancer Res 11: 1021-1027.
27. Okami J, Simeone DM, Logsdon CD. (2004). Cancer Res 64: 5338-5346.
28. Pfaffl MW. (2001). Nucleic Acids Res 29: e45.
29. Rubin H. (2001). Adv Cancer Res 83: 159-207.
30. Semenza GL. (2003). Nat Rev Cancer 3: 721-732.
31. Sowter HM, Ferguson M, Pym C, Watson P, Fox SB, Han C et al. (2003). J Pathol 201: 573-580.
32. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. (2001). Cancer Res 61: 6669-6673.
33. Stadler P, Becker A, Feldmann HJ, Hansgen G, Dunst J, Wurschmidt F et al. (1999). Int J Radiat Oncol Biol Phys 44: 749-754.
34. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP et al. (2002). Nat Genet 31: 141-149.
35. Tomes L, Emberley E, Niu Y, Troup S, Pastorek J, Strange K et al. (2003). Breast Cancer Res Treat 81: 61-69.
36. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S et al. (2000). Mol Cell Biol 20: 5454-5468.
37. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A et al. (2000). Cancer Res 60: 7075-7083.
38. Yasuda M, Theodorakis P, Subramanian T, Chinnadurai G. (1998). J Biol Chem 273: 12415-12421.
39. Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS. (2002). Science 295: 1526-1528.